Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Public ClinicalTrials.gov record NCT00940225. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Discontinuation Study of XL184 in Subjects With Advanced Solid Tumors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2 study to evaluate the efficacy and safety of cabozantinib (XL184) in subjects with selected advanced tumor types.
Study identification
- NCT ID
- NCT00940225
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 730 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2009 (Actual)
- Primary completion
- May 2013 (Actual)
- Completion
- Jun 2014 (Actual)
- Last update posted
- Apr 25, 2024
2009 – 2014
United States locations
- U.S. sites
- 34
- U.S. states
- 23
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Oncology of Arizona | Scottsdale | Arizona | 85258 | — |
| University of California Davis Cancer Center | Sacramento | California | 95817 | — |
| University of California, San Francisco | San Francisco | California | 94115 | — |
| Stanford University Medical Center | Stanford | California | 94305 | — |
| Rocky Mountain Cancer Centers | Denver | Colorado | 80218 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06520 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33916 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| Central Indiana Cancer Centers | Indianapolis | Indiana | 46227 | — |
| Tulane University Health Sciences Center | New Orleans | Louisiana | 70112 | — |
| Dana Farber Cancer Center | Boston | Massachusetts | 02115 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| University of Missouri Health Care | Columbia | Missouri | 65203 | — |
| Kansas City Cancer Center | Lee's Summit | Missouri | 64064 | — |
| Midwest Hematology Oncology Consultants | St Louis | Missouri | 63136 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | — |
| NYU Clinical Cancer Center | New York | New York | 10016 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Ohio State University GYN Oncology | Hilliard | Ohio | 43026 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73190 | — |
| Cancer Care Associates | Tulsa | Oklahoma | 74104 | — |
| Northwest Cancer Specialists | Tualatin | Oregon | 97062 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Cancer Centers of the Carolinas, ITOR | Greenville | South Carolina | 29605 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| Texas Oncology - Central Austin Cancer Center | Austin | Texas | 78731 | — |
| Mary Crowley Medical Research Center | Dallas | Texas | 75246 | — |
| University of Texas, M. D., Anderson Cancer Center | Houston | Texas | 77030 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Fairfax Northern Virginia Hematology Oncology | Fairfax | Virginia | 22031 | — |
| University of Washington | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00940225, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 25, 2024 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00940225 live on ClinicalTrials.gov.